These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 27590431)

  • 21. Social science. A risky science communication environment for vaccines.
    Kahan DM
    Science; 2013 Oct; 342(6154):53-4. PubMed ID: 24092722
    [No Abstract]   [Full Text] [Related]  

  • 22. Interleukin-31 Polymorphisms and Serum IL-31 Level in Patients with Mastocytosis: Correlation with Clinical Presen-tation and Pruritus.
    Lange M; Gleń J; Zabłotna M; Nedoszytko B; Sokołowska-Wojdyło M; Rębała K; Ługowska-Umer H; Niedoszytko M; Górska A; Sikorska M; Zawadzka A; Nowicki R
    Acta Derm Venereol; 2017 Jan; 97(1):47-53. PubMed ID: 27276346
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An analysis of the reactivity of vaccines administered in Texas from 1991 through 1999.
    Geier DA; Geier MR
    Tex Med; 2002 Jul; 98(7):50-4. PubMed ID: 12134752
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anaphylactic reaction to white-faced hornet sting and elevated baseline (asymptomatic) serum tryptase.
    Lieberman P; Schwartz LB
    J Allergy Clin Immunol Pract; 2013; 1(3):315. PubMed ID: 24565497
    [No Abstract]   [Full Text] [Related]  

  • 25. Vaccination site and risk of local reactions in children 1 through 6 years of age.
    Jackson LA; Peterson D; Nelson JC; Marcy SM; Naleway AL; Nordin JD; Donahue JG; Hambidge SJ; Balsbaugh C; Baxter R; Marsh T; Madziwa L; Weintraub E
    Pediatrics; 2013 Feb; 131(2):283-9. PubMed ID: 23319538
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnosis and classification of mastocytosis in non-specialized versus reference centres: a Spanish Network on Mastocytosis (REMA) study on 122 patients.
    Sánchez-Muñoz L; Morgado JM; Álvarez-Twose I; Matito A; Garcia-Montero AC; Teodosio C; Jara-Acevedo M; Mayado A; Mollejo M; Caldas C; González de Olano D; Escribano L; Orfao A
    Br J Haematol; 2016 Jan; 172(1):56-63. PubMed ID: 26456532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vaccines: an issue of trust. Misinformation and government foot-dragging are fanning fears.
    Consum Rep; 2001 Aug; 66(8):17-21. PubMed ID: 11725793
    [No Abstract]   [Full Text] [Related]  

  • 28. Public fear of vaccination: separating fact from fiction.
    Amanna I; Slifka MK
    Viral Immunol; 2005; 18(2):307-15. PubMed ID: 16035942
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevated baseline serum tryptase, mastocytosis and anaphylaxis.
    Müller UR
    Clin Exp Allergy; 2009 May; 39(5):620-2. PubMed ID: 19400907
    [No Abstract]   [Full Text] [Related]  

  • 30. Diagnostic value of tryptase in anaphylaxis and mastocytosis.
    Schwartz LB
    Immunol Allergy Clin North Am; 2006 Aug; 26(3):451-63. PubMed ID: 16931288
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of age and heterophilic interference on the basal serum tryptase, a risk indication for anaphylaxis, in 1,092 dermatology patients.
    Schliemann S; Seyfarth F; Hipler UC; Elsner P
    Acta Derm Venereol; 2012 Sep; 92(5):484-9. PubMed ID: 22170044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [What are the hazards of vaccinations in childhood?].
    Borsche A
    ZFA (Stuttgart); 1976 May; 52(13):666-74. PubMed ID: 942564
    [No Abstract]   [Full Text] [Related]  

  • 33. Oxidative stress markers are increased in patients with mastocytosis.
    Gangemi S; Minciullo PL; Magliacane D; Saitta S; Loffredo S; Saija A; Cristani M; Marone G; Triggiani M
    Allergy; 2015 Apr; 70(4):436-42. PubMed ID: 25630934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Large maculopapular cutaneous lesions are associated with favorable outcome in childhood-onset mastocytosis.
    Wiechers T; Rabenhorst A; Schick T; Preussner LM; Förster A; Valent P; Horny HP; Sotlar K; Hartmann K
    J Allergy Clin Immunol; 2015 Dec; 136(6):1581-1590.e3. PubMed ID: 26152315
    [TBL] [Abstract][Full Text] [Related]  

  • 35. No blame--no gain.
    Templeman-Kluit A
    CMAJ; 2008 Jan; 178(2):140-1. PubMed ID: 18195280
    [No Abstract]   [Full Text] [Related]  

  • 36. Supplementary report: surveillance of adverse events following immunisation among children aged less than 7 years in Australia, 1 January to 30 June 2010.
    Mahajan D; Menzies R; Cook J; Macartney K; Mclntyre P
    Commun Dis Intell Q Rep; 2011 Mar; 35(1):21-8. PubMed ID: 21698980
    [No Abstract]   [Full Text] [Related]  

  • 37. Serum tryptase levels in patients with mastocytosis: correlation with mast cell burden and implication for defining the category of disease.
    Sperr WR; Jordan JH; Fiegl M; Escribano L; Bellas C; Dirnhofer S; Semper H; Simonitsch-Klupp I; Horny HP; Valent P
    Int Arch Allergy Immunol; 2002 Jun; 128(2):136-41. PubMed ID: 12065914
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postvaccination thrombocytopenia in Canada.
    Sauvé LJ; Bettinger J; Scheifele D; Halperin S; Vaudry W; Law B;
    Pediatr Infect Dis J; 2010 Jun; 29(6):559-61. PubMed ID: 20160658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Checked out].
    Kinderkrankenschwester; 2014 Apr; 33(4):149-50. PubMed ID: 24834683
    [No Abstract]   [Full Text] [Related]  

  • 40. Cutaneous manifestations in Hymenoptera and Diptera anaphylaxis: relationship with basal serum tryptase.
    Potier A; Lavigne C; Chappard D; Verret JL; Chevailler A; Nicolie B; Drouet M
    Clin Exp Allergy; 2009 May; 39(5):717-25. PubMed ID: 19302252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.